The rush to capitalise on GLP-1 drugs success is having wider implications for the pharmaceutical industry: Manufacturing capacity is being diverted from other therapeutic areas to meet GLP-1 demand
Our low-temperature Lithium batteries discharging current of 0.2C at -50 is over 60% efficiency, over 80% efficiency at -40, and around 80% efficiency at -30
When NAD+ levels drop, ATP production becomes less efficient
(And What You Can Do Instead) Weight loss drugs like Ozempic and Wegovy have become household names over the last few years thanks to their effectiveness in suppressing appetite and helping people shed unwanted pounds
Sources Koenig, W., Sund, M., Frhlich, M., Fischer, H